Contact
Please use this form to send email to PR contact of this press release:
Ovid Therapeutics Announces Initial Data with Soticlestat in CDKL5 Deficiency Disorder and Dup15q Syndrome
TO:
Please use this form to send email to PR contact of this press release:
Ovid Therapeutics Announces Initial Data with Soticlestat in CDKL5 Deficiency Disorder and Dup15q Syndrome
TO: